Journal of Jilin University(Medicine Edition) ›› 2025, Vol. 51 ›› Issue (4): 914-920.doi: 10.13481/j.1671-587X.20250407

• Research in basic medicine • Previous Articles     Next Articles

Effect of recombinant human growth hormone on depression-like behaviors induced by chronic restraint stress in mice and its mechanism

Jianfang LI,Yinghua LI,Yawen LIAN,Xiaowei CHEN()   

  1. Department of Rehabilitation Medicine,First Hospital,Jilin University,Changchun 130021,China
  • Received:2024-08-08 Accepted:2024-10-31 Online:2025-07-28 Published:2025-08-25
  • Contact: Xiaowei CHEN E-mail:cxw@jlu.edu.cn

Abstract:

Objective To observe the effects of recombinant human growth hormone (rh-GH) on depressive-like behavior in mice with chronic restraint stress (CRS), and to discuss its possible mechanism. Methods The CRS method was used to establish an animal model of depression; a total of 45 mice were didided into control group (non-modeled, n=15), and CRS model group (modeled, n=30) the sucrose preference test (SPT) was used to detect the sucrose preference rate of the mice; the tail suspension test (TST) was used to detect the immobility time of the mice; the open field test (OFT) was used to detect the total moving distance of the mice within 5 min and the time spent in the central area. The CRS mice were randomly divided into CRS model+saline group and CRS model+rh-GH group(n=10); the mice in CRS model+saline group were injected with normal saline; the mice in CRS model+rh-GH group were subcutaneously injected with rh-GH daily for 1 month; the peripheral blood of the mice was collected before and after intervention to detect the expression levels of growth hormone (GH) and insulin-like growth factor Ⅰ (IGF-Ⅰ) proteins in serum; after all behavioral experiments, the hippocampus tissue was taken to detect the expression level of synapsin-1 (SYN-1) protein in the tissue of the mice. Results Compared with control group, the body weight of the mice in CRS model group was significantly decreased (P<0.01), the sucrose preference rate in SPT was significantly decreased (P<0.01), the immobility time in TST was significantly prolonged (P<0.01); in OFT, the total moving distance of mice showed no significant change (P>0.05), while the time spent in the central area was significantly shortened (P<0.05). Compared with control group, the expression levels of GH and IGF-Ⅰ proteins in serum of the mice in CRS model group were significantly decreased (P<0.01). Compared with CRS model+saline group, the sucrose preference rate in SPT of the mice in CRS model+rh-GH group was significantly increased (P<0.01), the immobility time in TST was significantly shortened (P<0.05), the total moving distance in OFT showed no significant difference (P>0.05), and the time spent in the central area was significantly increased (P<0.01). Compared with model+saline group, the expression levels of GH and IGF-I proteins in serum of the mice in CRS model+rh-GH group were significantly increased (P<0.01). Compared with model group, the expression level of SYN-1 protein in hippocampus tissue of mice in drug-treated model group was significantly increased (P<0.05). Conclusion rh-GH has ameliorative effects on depressive-like behavior induced by chronic restraint stress in mice, and its mechanism may be associated with regulation of the GH/IGF-Ⅰ axis and increased expression of SYN-1 in hippocampus tissue.

Key words: Depressive-like behavior, Recombinant human growth hormone, Insulin-like growth factor Ⅰ, Synapsin-1, Chronic restraint stress

CLC Number: 

  • R749.4